Technology

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

June 02, 2026 tristan manalac biospace
IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

Read Full Article

This article was originally published on biospace. Click the button above to read the complete article.

Related Articles

Yoco's next chapter: can a European fintech architect build Africa's financial future?

Yoco's next chapter: can a European fintech architect build Africa's financial future?
Metro mayor puts brakes on roll-out of driverless cars to West of England

Metro mayor puts brakes on roll-out of driverless cars to West of England

FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting

SEALSQ Announces Majority Investment in Wecan Group and CHF 5 Million Strategic Commitment to Accelerate Post-Quantum AI Compliance Co-Pilot for Global Financial Institutions

SIKA APPOINTS NEW MEMBER OF GROUP MANAGEMENT AND ADVANCES DIGITAL TRANSFORMATION
Frances Josephine Henning

Frances Josephine Henning